Literature DB >> 12499248

Amplification of wild-type K-ras promotes growth of head and neck squamous cell carcinoma.

Michael Hoa1, Shannon L Davis, Sarah J Ames, Remco A Spanjaard.   

Abstract

In contrast to many other tumors of different lineage, oncogenic ras mutations are rarely found within head and neck squamous cell carcinoma (HNSCC). On the other hand, increased expression of wild-type K-ras in HNSCC tumor material has been noticed, but the potential physiological consequences of this observation have not yet been experimentally assessed. The current study addresses this issue by modulating K-ras expression in HNSCC cell lines and primary keratinocytes and determining its effects on cell growth and survival in vitro. Consistent with earlier reports using patient tumor material, Western blot analysis of four HNSCC lines (SCC-9, SCC-15, SCC-25, and FaDu) revealed varying but universally increased protein expression of K-ras relative to keratinocytes. All HNSCC lines expressed wild-type K-ras mRNA based on a random sequencing of eight K-ras cDNA samples obtained by reverse transcription-PCR from each HNSCC line (P <or= 0.00391). Transfection of keratinocytes with a plasmid expression vector containing wild-type K-ras cDNA resulted in dramatically increased proliferation and survival compared with control-transfected or untransfected keratinocytes. Conversely, transfection of FaDu cells, which express the highest level of endogenous K-ras, with K-ras antisense oligonucleotides but not control oligonucleotides significantly reduced cellular proliferation (P <or= 0.0022). These results show that the level of K-ras protein expression is a major determinant of proliferation of HNSCC cells and keratinocytes and suggest that amplification of nonmutated K-ras in HNSCC contributes to tumor growth. These novel findings may have important ramifications for potential K-ras-targeted interventions in the treatment of HNSCC.

Entities:  

Mesh:

Year:  2002        PMID: 12499248

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  33 in total

1.  A critical role of c-Cbl-interacting protein of 85 kDa in the development and progression of head and neck squamous cell carcinomas through the ras-ERK pathway.

Authors:  Takahiro Wakasaki; Muneyuki Masuda; Hiroaki Niiro; Siamak Jabbarzadeh-Tabrizi; Kumiko Noda; Tadayoshi Taniyama; Shizuo Komune; Koichi Akashi
Journal:  Neoplasia       Date:  2010-10       Impact factor: 5.715

2.  Lack of association between let-7 binding site polymorphism rs712 and risk of nasopharyngeal carcinoma.

Authors:  Xin-Min Pan; Jing Jia; Xiao-Min Guo; Zhao-Hui Li; Zhen Zhang; Hao-Jie Qin; Guo-Hui Xu; Lin-Bo Gao
Journal:  Fam Cancer       Date:  2014-03       Impact factor: 2.375

3.  A let-7 binding site polymorphism rs712 in the KRAS 3' UTR is associated with an increased risk of gastric cancer.

Authors:  Zhao-Hui Li; Xin-Min Pan; Bao-Wei Han; Xiao-Min Guo; Zhen Zhang; Jing Jia; Lin-Bo Gao
Journal:  Tumour Biol       Date:  2013-06-02

4.  Altered peritumoral microRNA expression predicts head and neck cancer patients with a high risk of recurrence.

Authors:  Federica Ganci; Andrea Sacconi; Valentina Manciocco; Renato Covello; Maria Benevolo; Francesca Rollo; Sabrina Strano; Sara Valsoni; Silvio Bicciato; Giuseppe Spriano; Paola Muti; Giulia Fontemaggi; Giovanni Blandino
Journal:  Mod Pathol       Date:  2017-07-21       Impact factor: 7.842

5.  ERK2-dependent reactivation of Akt mediates the limited response of tumor cells with constitutive K-RAS activity to PI3K inhibition.

Authors:  Mahmoud Toulany; Minjmaa Minjgee; Mohammad Saki; Marina Holler; Friedegund Meier; Wolfgang Eicheler; H Peter Rodemann
Journal:  Cancer Biol Ther       Date:  2013-12-09       Impact factor: 4.742

6.  Activation of sterile20-like kinase 1 in proteasome inhibitor bortezomib-induced apoptosis in oncogenic K-ras-transformed cells.

Authors:  Fuminori Teraishi; Wei Guo; Lidong Zhang; Fengqing Dong; John J Davis; Takehiko Sasazuki; Senji Shirasawa; Jinsong Liu; Bingliang Fang
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

Review 7.  Molecular changes in the multistage pathogenesis of head and neck cancer.

Authors:  Brian J Park; Simion I Chiosea; Jennifer R Grandis
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

8.  Mutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma.

Authors:  Karl C Bruckman; Frank Schönleben; Wanglong Qiu; Victoria L Woo; Gloria H Su
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-09-01

9.  Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2.

Authors:  Li Lai; Junchen Liu; Dong Zhai; Qingxiang Lin; Lijun He; Yanmin Dong; Jing Zhang; Binbin Lu; Yihua Chen; Zhengfang Yi; Mingyao Liu
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

10.  A let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers.

Authors:  Brock C Christensen; Benjamin J Moyer; Michele Avissar; Lauren G Ouellet; Silvia L Plaza; Michael D McClean; Carmen J Marsit; Karl T Kelsey
Journal:  Carcinogenesis       Date:  2009-04-20       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.